BioNTech CEO interview: On boosters, the future of Covid-19, and the plan to make and ship the next vaccine in 3 months
For the first time since the pandemic began, BioNTech CEO Uğur Şahin made his way to the US, this time for a cancer drug conference in Washington, DC, last week. Prior to presenting his company’s poster on early, promising data for its CLDN6-targeted CAR-T, Şahin sat down with a small group of reporters and discussed his company’s blockbuster Covid-19 vaccine, and what’s to be expected from the pandemic moving forward.
Premium subscription required
Unlock this article along with other benefits by subscribing to one of our paid plans.